Nicole Hamblett: Clinical Trials

8 trials sponsored by Nicole Hamblett, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Not yet recruiting 1

Follow Nicole Hamblett: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rethinking Early Airway Clearence Therapies
As-needed hypertonic saline (HS), Twice daily hypertonic saline (HS), As-needed dornase alfa (DA) - Cystic Fibrosis (CF)
Not applicableNot yet recruitingNicole Hamblett4052026-12-152026-11-19
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
RecruitingNicole Hamblett4002024-09-182026-11-19
The PROMISE Pediatric Study 6 to 11 Years Old
Cystic Fibrosis, Cystic Fibrosis in Children
CompletedNicole Hamblett1252021-06-112026-04-27
Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study
Discontinuation of hypertonic saline (HS), Continuation of hypertonic saline (HS) - Cystic Fibrosis
Not applicableCompletedNicole Hamblett3702020-08-252024-10-01
Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
Discontinuation of dornase alfa (Dnase), Continuation of dornase alfa (Dnase) - Cystic Fibrosis
Not applicableCompletedNicole Hamblett4772020-08-252024-11-26
Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy
Cystic Fibrosis
CompletedNicole Hamblett9872020-08-252024-12-04
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function
Cystic Fibrosis
CompletedNicole Hamblett4902019-10-222025-01-28
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
Cystic Fibrosis
Active not recruitingNicole Hamblett50002018-01-152025-10-10

Conditions studied

Cystic Fibrosis (8)

Interventions

Deoxyribonucleases (1)

Countries

United States (8)  ·  Canada (1)

Top investigators

Nicole Mayer-Hamblett, PhD (5)  ·  Alex Gifford, MD, FCCP (3)  ·  David Nichols, MD (2)  ·  Steven Rowe, MD (2)  ·  Deepika Polineni, MD, MPH (1)  ·  Edith Zemanick, MD (1)  ·  Felix Ratjen, MD (1)  ·  Felix Ratjen, MD, PhD (1)  ·  Jonathan Rayment, MDCM, MSc, FRCPC (1)  ·  Margaret Rosenfeld, MD, MPH (1)  ·  Michael Konstan, MD (1)  ·  Scott Donaldson, MD (1)

Results publications

PMID 33465316, PMID 33735508, PMID 34784492, PMID 36280527, PMID 36343646, PMID 36976651, PMID 37100705, PMID 38153868, PMID 40540670, PMID 40961158